Assignee
ALGERNON PHARMACEUTICALS INC
CA·2 granted patents·4 pending applications·0 citations·filing 2019–2022
Top patents by PatentIndex Score
6 records- 0160US12280026B2Use of repirinast in the prophylaxis or treatment of renal fibrosis or kidney diseaseALGERNON PHARMACEUTICALS INC·Filed 2019·Granted Apr 22, 2025·0 cites·8 claims
- 0260US11744808B2Compositions and methods for treating non-alcoholic steatohepatitisALGERNON PHARMACEUTICALS INC·Filed 2019·Granted Sep 5, 2023·0 cites·6 claims
- 0354US2025009730A1Ifenprodil salts and therapeutic uses thereofALGERNON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0453US2024122897A1Dmt salts and their use to treat brain injuryALGERNON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0547US2021290604A1Compounds for treatment of inflammatory bowel disease and methods thereofALGERNON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0646US2022117951A1Compositions and methods for treating idiopathic pulmonary fibrosisALGERNON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ALGERNON PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →